Staar Surgical Analyst Ratings
BTIG Upgrades Staar Surgical to Buy, Announces $46 Price Target
Tandem Diabetes Care Analyst Ratings
Oppenheimer Maintains Outperform on Tandem Diabetes Care, Raises Price Target to $58
TransMedics Gr Analyst Ratings
CL King Initiates TransMedics at Buy Rating With $161 Price Target
Glaukos Analyst Ratings
NovoCure Analyst Ratings
TransMedics Gr Analyst Ratings
Wedbush Adjusts Price Target on NovoCure to $24 From $21, Maintains Neutral Rating
Glaukos Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Glaukos (GKOS) and Arcus Biosciences (RCUS)
Strong Market Reclaim and Innovative Pipeline Underpin Buy Rating for Tandem Diabetes Care
Tandem Diabetes Care Analyst Ratings
Globus Medical Analyst Ratings
Analysts Are Bullish on Top Healthcare Stocks: Globus Medical (GMED), Irhythm Technologies (IRTC)
Analysts Offer Insights on Healthcare Companies: Genmab (GMAB), Perspective Therapeutics (CATX) and Glaukos (GKOS)
Analysts Offer Insights on Healthcare Companies: ACELYRIN, INC. (SLRN), Arrowhead Pharmaceuticals (ARWR) and NovoCure (NVCR)
Analysts' Top Healthcare Picks: Silk Road Medical (SILK), Eli Lilly & Co (LLY)
Citi Upgrades Edwards, Tandem; Cuts Nevro, Establishment Labs